Overview
ABSTRACT
In the search of new biopharmaceuticals to find more efficient treatment, to develop new therapeutic strategies and to improve medical answer, the marine world offers an untapped deposit for the discovery of original molecules. With the emergence of the glycoscience underlying the crucial roles of polysaccharides in major biological functions and the expansion of marine biotechnologies, the potential of marine polysaccharides as an innovative source of new pharmaceuticals has emerged and gained considerable attention. The aim of this article is the description of the principal marine polysaccharides, their main sources, their structural diversity (that can be increased by chemical and/or enzymatic modification) and their potential for therapeutic applications in major diseases.
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHORS
-
Corinne SINQUIN: Research engineer - Ifremer, Laboratory of biotechnology and marine molecules, Atlantic Center, Nantes, France
-
Sylvia COLLIEC-JOUAULT: Research Executive, HDR - Ifremer, Laboratory of biotechnology and marine molecules, Atlantic Center, Nantes, France
INTRODUCTION
Thanks to its diversity and complexity, the marine world offers an infinite number of original molecules yet to be discovered. One of the challenges facing research today is to explore marine biodiversity with a view to exploiting it. The study of marine biodiversity, and marine polysaccharides in particular, represents a major challenge for research and biotechnology.
Indeed, thanks to their great structural diversity and specific properties, terrestrial and marine polysaccharides already occupy a sometimes unsuspected but nonetheless important place in our daily lives (food additives, toothpaste, textiles, etc.). As far as polysaccharides are concerned, several sources are already being exploited: terrestrial plants and animals, algae and bacteria. Since 1930, algal polysaccharides have been widely used in the food, cosmetics and pharmaceutical industries, in agriculture and, more recently, in biotechnology. Bacterial polysaccharides are currently the focus of major research and development, including glycosaminoglycans (hyaluronan and heparin precursors) and alginate. Bacterial origin enables us to fully control polysaccharide production and avoid using sources that may contain unconventional transmissible agents and viruses, such as mainly animal sources (porcine and bovine). Since the discovery of deep ocean hydrothermal springs and an exceptional microbial world, strain libraries have been set up to isolate new molecules, such as thermostable enzymes or original polysaccharides.
Polysaccharides are complex macromolecules found in all kingdoms (plant, animal and bacterial). Polysaccharides are made up of strings of osidic units linked by glycosidic bonds. The motif repeated n times, or repeating unit, may be made up of the same monosaccharide (homosaccharide) or several different motifs (heterosaccharide). The polysaccharide can be characterized by this repeating sequence made up of neutral oses (glucose, galactose, xylose, fucose...) or acid oses (glucuronic, galacturonic, iduronic...) or hexosamines (N-acetyl-glucosamine, N-acetyl-galactosamine). Polysaccharides can also be substituted by organic (acetate, lactate, pyruvate, succinate) or inorganic (phosphate, sulfate...) groups. The physico-chemical properties of polysaccharides depend on their molar mass, generally ranging from 100,000 to several million grams per mole, their chemical composition, and finally their structure: linear, branched, with or without substituents, their position and branching. Thanks to their almost infinite structural diversity, each polysaccharide characterized by its repeating unit is unique, and thus offers specific functional properties: thickening, stabilizing or gelling properties already widely exploited in the food and pharmaceutical industries, but also specific biological...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
KEYWORDS
state of the art | functionalisation | extraction | Depolymerisation | Fermentation | Healthcare | Biotechnology | biochemistry | microbiology
CAN BE ALSO FOUND IN:
Home Biomedical - pharma Healthcare technologies Marine polysaccharides for healthcare applications
Home Biomedical - pharma Drugs and pharmaceuticals Marine polysaccharides for healthcare applications
Home Food–Chem–Bio industry processes Bioprocesses and bioproductions Marine polysaccharides for healthcare applications
This article is included in
Plastics and composites
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Marine polysaccharides and their health applications
Bibliography
Directory
Manufacturers – Suppliers – Distributors (non-exhaustive list)
The main industrial producers of phycocolloids are :
Cargill http://www.cargillfoods.com/emea/en/products/hydrocolloids/index.jsp
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference